Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In CroatiaResearchers compared SM-13496 40mg, SM-13496 80mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Tokyo, EtcResearchers compared SM-13496 and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including TokyoThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumThis study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaThis study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomA Multicenter, Double-blind, Study of the Efficacy and Safety of Aripiprazole in Combination With Lamotrigine in the Long-term Maintenance Treatment of Patients With Bipolar I Disorder With a Recent Manic or Mixed Episode
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.